UsAgainstAlzheimer’s Praises Senate Appropriations Committee’s Proposed $354 Million Increase for Alzheimer’s Research at NIH
Urges Bipartisan Support to Continue Groundbreaking Alzheimer’s Research
Washington, D.C. (November 10, 2020) – George Vradenburg, chairman and co-founder of UsAgainstAlzheimer’s, issued the following statement on the proposed $354 million increase for Alzheimer’s research at the National Institutes of Health by the Senate Appropriations Committee. The legislation would increase research spending to more than $3.1 billion and is much larger than the $35 million increase in the House of Representatives funding bill for NIH Alzheimer’s research. Once the Senate passes its version of the FY21 spending bill, both sides need to reach agreement on a compromise funding bill.
“Alzheimer’s disease is a looming chronic disease pandemic that threatens millions of families in our nation, and this proposed $354 million increase is critically needed for continued breakthrough NIH research.
“President-elect Biden has made curing Alzheimer’s one of his top priorities, and the path to a cure will come through expanded spending on research funding. COVID-19 has shown how essential it is for the nation to invest in treatment research, and we applaud the subcommittee’s commitment to research that can help flatten the curve for the Alzheimer’s pandemic.
“The Senate’s proposed increase matches the spending request by the Alzheimer’s community, and we are so thankful for the leadership of Subcommittee Chairman Sen. Roy Blunt, R-MO, and Sen. Patty Murray, D-WA, the top subcommittee Democrat, in getting this increased funding.
“We urge the Senate to approve this $354 million increased investment in research into effective treatments and prevention of this disease. We call on Congress then to adopt the higher number in the Senate-House compromise bill to continue to expand this vital research.”